Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us

    News: oncology

    Hernanz-Schulman to chair commission of the ACR

    Monday, July 2nd, 2012

    Vanderbilt’s Marta Hernanz-Schulman, M.D., has been named to the Board of Chancellors of the American College of Radiology (ACR) as chair of the Pediatric Commission. Hernanz-Schulman, professor of Radiology and Radiological Sciences and professor of Pediatrics, currently serves as medical director of Diagnostic Imaging at the Monroe Carell Jr. Children’s Hospital at Vanderbilt. The American […]

    VUSM to Host IOM Meeting

    Friday, April 20th, 2012

    The Institute of Medicine of the National Academies (IOM), in conjunction with Vanderbilt University School of Medicine, will hold a regional meeting Monday, April 23, 4–6 p.m. in 208 Light Hall. The presentation, “Potential and Pitfalls of Gene and Omics-Based Treatment for Cancer,” will highlight recent advances in cancer research based on gene sequencing, along […]

    Oncology Named Among Nation’s Best

    Friday, March 23rd, 2012

    Becker’s Hospital Review has named Vanderbilt University Medical Center to its list of 70 Hospitals and Health Systems with Great Oncology Programs. These hospitals are deemed to be on the cutting edge of cancer treatment, prevention and research, and the Becker’s Hospital Review editorial team selected them based on clinical accolades, quality care and contributions […]

    Cancer Center Debuts Clinic in Green Hills

    Friday, August 19th, 2011

    Vanderbilt-Ingram Cancer Center has opened a free-standing cancer clinic in Green Hills to give cancer patients more options for their oncology care. VICC Green Hills provides many of the same services available at the main VICC campus, including access to board-certified cancer physicians and specially trained oncology nurses and pharmacists. Patients can see an oncologist, […]

    Breast Cancer Study Combines Therapies

    Friday, March 18th, 2011

    Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies by Vanderbilt-Ingram Cancer Center (VICC) investigators. The findings, reported in two papers in the Proceedings of the National Academy of Sciences (PNAS), suggest that upregulation of the HER3 receptor limits the effectiveness of two classes […]